Howard University Cancer Center — Washington D.C., District of Columbia

Howard University Cancer Center is a clinical research site located in Washington D.C., District of Columbia, United States 20060.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

Howard University Cancer Center has participated in 7 clinical trials.

Therapeutic areas: Cancer, Breast Cancer, Brain Cancer.

Sponsors: Inova Health Care Services, Fox Chase Cancer Center, Alliance for Clinical Trials in Oncology.

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Howard University Cancer Center?

Howard University Cancer Center has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Howard University Cancer Center conducted?

Howard University Cancer Center has 7 clinical trials on record. Their work covers Cancer, Breast Cancer, Brain Cancer.

Is Howard University Cancer Center accredited by Crixeo Health?

Yes — Howard University Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Howard University Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.